BioNexus Gene Lab Corp's total assets for Q2 2025 were $9.42M, a decrease of -0.62% from the previous quarter. BGLC total liabilities were $1.90M for the fiscal quarter, a 11.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.